جست‌وجوی استاد و پژوهشگر

Keith Alexander Sharkeyمشاهده پروفایل

استاد

• Enteric nervous system
• Gut-brain axis
• Endocannabinoid system
• +۳ مورد دیگر

Dr. Keith Alexander Sharkey is a Professor in the Department of Physiology and Pharmacology at the Cumming School of Medicine, University of Calgary. He is also a Full Member of both the Hotchkiss Brain Institute and The Calvin, Phoebe and Joan Snyder Institute for Chronic Diseases. Dr. Sharkey has been at the University of Calgary since his appointment as Assistant Professor in 1990, dedicating his career to understanding the neural control of the gastrointestinal tract. From 2005-2021, he held the Crohn's and Colitis Canada Chair in Inflammatory Bowel Disease Research, demonstrating his longstanding commitment to advancing knowledge in gastrointestinal sciences. Dr. Sharkey's educational journey began with a BSc (Hons) in Nutrition from the University of London in 1981, followed by a PhD in Physiology from the University of Liverpool in 1985. After completing postdoctoral training in Hungary, the UK, and Canada, he joined the University of Calgary faculty in 1990, where he has remained throughout his distinguished academic career. Dr. Sharkey's research program centers on understanding the physiology and pathophysiology of the neural control of the gastrointestinal tract and brain-gut interactions in health and disease. His laboratory investigates two main areas: the role of the endocannabinoid system in regulating GI motility and intestinal barrier function, and the physiology of the enteric nervous system in controlling motility and barrier function. His work employs state-of-the-art approaches including live cell imaging and molecular genetics. Recent publications show his expanding interest in connections between gut function and neurodegenerative conditions like ALS, with multiple 2024-2025 papers examining sexual dimorphism in disease processes and gut-brain axis mechanisms. Fellow, Royal Society of Canada (2024) Cumming School of Medicine's van de Sande Distinguished Achievement Award for Mentorship (2021) Distinguished Research Award, American Physiological Society (2021) Finkelstein Award for Excellence, Crohn's and Colitis Canada (2016) Fellow, Canadian Academy of Health Sciences (2015) Fellow, Canadian Association of Gastroenterology (2015) Killam Annual Professor Award, University of Calgary (2013) Dr. Sharkey has mentored numerous students throughout his career, as evidenced by his 2021 Mentorship Award. His research is supported by significant funding, including a CIHR Foundation grant exploring how enteric nerves and glia maintain intestinal homeostasis. He has also participated in university strategic initiatives focused on Brain and Mental Health (2015-2021) and Infections, Inflammations and Chronic Diseases (2015-2021), demonstrating his interdisciplinary approach. The Sharkey Lab provides a safe, inclusive, and diverse research environment that encourages open scientific exchange from diverse viewpoints. His laboratory is actively engaged in multiple collaborative projects, including investigations with UBC Okanagan on diet and probiotics targeting the gut-brain metabolic interactome, and with University of Calgary colleagues studying gut microbiota's role in ALS. Dr. Sharkey continues to advance our understanding of neural mechanisms controlling gastrointestinal function with upcoming courses scheduled for Fall 2024 and Winter 2025.

Fredric B. Meyerمشاهده پروفایل

استاد

• Neurosurgery
• Brain Tumors
• Cerebrovascular Diseases
• +۶ مورد دیگر

Fredric B. Meyer, M.D., is a Professor of Neurologic Surgery and the Juanita Kious Waugh Executive Dean of Education at the Mayo Clinic College of Medicine and Science. He serves as the Enterprise Chair of the Department of Neurologic Surgery and Dean of the Mayo Clinic Alix School of Medicine. His expertise spans complex brain tumor surgery, cerebrovascular diseases (e.g., aneurysms, moyamoya disease), and epilepsy treatment. Dr. Meyer holds the Alfred Uihlein Family Professorship and has received numerous awards for teaching and clinical excellence. Education: MD from Boston University (1981), BA in Biology from the University of Pennsylvania (1977). Professional highlights include leadership roles in the American Board of Neurological Surgery and the American Academy of Neurological Surgery. His research focuses on advancing neurosurgical techniques, regenerative medicine, and improving patient outcomes through clinical registries and molecular studies. Key awards include the Mayo Foundation Distinguished Educator Award (2011) and the Teacher of the Year Award (multiple years). He leads the Neuroregenerative Medicine & Surgery Program at Mayo's Center for Regenerative Medicine.

Hongfu Sunمشاهده پروفایل

مدرس ارشد

• Biomedical Engineering
• Deep Learning
• Magnetic Resonance Imaging (MRI)
• +۳ مورد دیگر

Hongfu Sun is a Senior Lecturer at the School of Engineering, University of Newcastle. His research focuses on innovating MRI mechanisms for clinical and research applications, particularly in Quantitative Susceptibility Mapping (QSM). He is internationally recognized as a pioneer in QSM and integrates MR physics, signal processing, and AI for medical imaging advancements. Sun holds a Ph.D. in Biomedical Engineering from the University of Alberta, Canada. Professional Experience: Senior Lecturer at University of Newcastle (current) ARC DECRA Research Fellow at University of Queensland (2021–2023) Postdoctoral Researcher at University of Calgary (2015–2019) Research Interests: Focuses on MRI innovation, including QSM, deep learning for medical imaging, and AI-driven reconstruction techniques. His work addresses challenges like sub-millimeter resolution and artifact reduction in MRI. Recent projects involve generative AI models for MRI analysis and accelerated quantitative imaging methods. Grants and Funding: AU$1.69M in grants, including a 2021 ARC DECRA for microscopic MRI techniques 2024 NHMRC grant for Parkinson’s disease MRI diagnostics Teaching: Course coordinator for Medical Imaging and Signal Processing at University of Newcastle Focus on biomedical imaging, computational methods, and signal analysis Labs/Teams: Leads research in MRI innovation, collaborating on QSM, deep learning applications, and translational imaging techniques. Active in interdisciplinary projects combining physics, AI, and clinical medicine.

Freek J. Beekmanمشاهده پروفایل

استاد

• Biomedical Imaging
• Nuclear Imaging
• Image Reconstruction Algorithms
• +۱۲ مورد دیگر

Prof. Freek J. Beekman is a Full Professor and head of the Biomedical Imaging section within the Department of Radiation Science & Technology at Delft University of Technology (TU Delft), Faculty of Applied Sciences. He is a leading figure in biomedical imaging, with extensive contributions to nuclear imaging technologies, including SPECT, PET, and CT. His research spans detector development, image reconstruction algorithms, hybrid photonic imaging, and the application of artificial intelligence in medical imaging. Research Interests: His work focuses on advancing imaging modalities through innovations in hardware (e.g., multi-pinhole collimators) and software (e.g., deep learning for attenuation correction). He has pioneered ultra-high-resolution imaging systems, particularly for preclinical and clinical SPECT, and has developed integrated platforms like U-SPECT-BioFluo. His recent research explores glymphatic delivery of nanoparticles, infection imaging, and AI-driven reconstruction techniques, reflecting a strong translational focus. Publication Trends: His most recent publications (2021–2023) emphasize deep learning in SPECT, multi-isotope imaging, high-resolution ex vivo systems, and applications in neuroimaging and oncology. The articles demonstrate a consistent focus on improving image quality, resolution, and clinical utility through physics-informed and AI-enhanced methods. Scientific Awards: NWO Physics Valorization Prize Innovation of the Year Award by the World Molecular Imaging Society (2015, 2018) Edward Hoffman Memorial Award (2017) Bruce Hasegawa Memorial Award (2021) FOM Valorization Award (2013) TU Delft Entrepreneurial Award (2010) Advising and Grants: While specific student names are not listed, his leadership in large collaborative projects and supervision of numerous publications suggests active mentoring. He has secured significant funding through national and international grants, evidenced by his invention of over 20 patent families and successful technology transfer. His founding and leadership of MILabs BV (sold to Rigaku) highlights his impact on commercialization and industry-academia collaboration. Labs and Teams: He leads the Biomedical Imaging research group at TU Delft, which develops cutting-edge imaging systems such as VECTor (SPECT-PET) and EXIRAD-HE. His teams have produced technologies used globally in academic and pharmaceutical research, contributing to tracer development and therapeutic innovation.

Alison Elderمشاهده پروفایل

دانشیار

• Toxicology of Inhaled Ultrafine Particles
• Engineered Nanomaterials
• Air Pollution and Neurodegeneration
• +۱۲ مورد دیگر

Alison Elder, Ph.D., is an Associate Professor in the Department of Environmental Medicine at the University of Rochester School of Medicine and Dentistry. She is affiliated with several research programs including the Environmental Health Sciences Center, the Inhalation Exposure Facility, the Toxicology Training Program (as Co-Director), the Lung Biology and Disease Program, and the Multidisciplinary Training in Pulmonary Research Program. Her research focuses on the toxicology of inhaled ultrafine particles (UFPs) and engineered nanomaterials, with implications for pulmonary, cardiovascular, and central nervous system health. Ph.D. in Environmental Toxicology, University of California, Irvine (1997) B.S. in Chemistry, Chatham College (1992) Post-doctoral Fellow, Department of Environmental Medicine, University of Rochester (1997–2000) Dr. Elder’s research centers on the health impacts of airborne particulate matter, particularly how age, co-pollutants, and health status influence responses to inhaled particles. Her work explores the translocation of particles to extrapulmonary tissues, including the brain, and their role in neurodegenerative diseases like Alzheimer’s. She investigates mechanisms such as oxidative stress, inflammation, and glymphatic dysfunction. Her lab also studies airborne micro- and nanoplastics, focusing on exposure characterization and health implications. Her recent publications span topics including Alzheimer’s disease models, glymphatic impairment, nanoparticle dissolution, and diesel exhaust effects on lung barriers. These works emphasize particle-induced inflammation, neurotoxicity, and the intersection of environmental exposure with neurological outcomes. Young Investigator Award, Society of Toxicology (2009) Cornerstone Alumna Award, Chatham University (2007) Graduate Student Fellowship, U.S. EPA (1995–1996) College Chemistry Award, Society for Analytical Chemists of Pittsburgh (1992) Dr. Elder mentors graduate students in toxicology and has trained numerous postdoctoral fellows and technicians. She leads an active research laboratory funded by NIH and DOD, investigating air pollution’s role in brain health and military burn pit exposures. Her collaborative research includes work with experts in neuroscience, materials science, and environmental engineering. She is also involved in national workshops on nanomaterial risk assessment and children’s environmental health. She leads the Elder Lab, which conducts studies on air pollution and Alzheimer’s disease, characterizes airborne micro- and nanoplastics, and develops models for nanoparticle toxicity. The lab uses advanced techniques in particle characterization, animal modeling, and cellular assays to assess health risks.

• Immunopsychiatry
• Neuroimaging
• Psychiatry
• +۵ مورد دیگر

Professor Neil Harrison is a Clinical Professor in Neuroimaging at Cardiff University's School of Medicine, leading the Immunopsychiatry Research Group at CUBRIC and the Haydn Ellis Building. He previously established the UK's first Clinical Immunopsychiatry Service in Sussex. His expertise spans neuroimaging, psychiatry, and immunology, focusing on how immune systems interact with brain function in mental illnesses like depression and Alzheimer’s. He holds grants from the MRC, Wellcome Trust, and Janssen Pharmaceutics. Education: PhD in Neuroscience from UCL’s Wellcome Trust Centre for Neuroimaging, psychiatry training at the Maudsley Hospital and National Hospital for Neurology, Queen Square. Research interests include neuroinflammation’s role in mental health, with a focus on translational approaches like wearable technology for early disease detection. He chairs the Psychoneuroimmunology Research Society and advises the Wellcome Trust’s Clinical Interview Committee. Grants and collaborations include work on imaging brain inflammation, chronic fatigue mechanisms, and translational immunopsychiatry. His lab investigates neuroimaging biomarkers and clinical applications of immunological insights in mental health.

Travis B. Thompsonمشاهده پروفایل

استادیار

• Mathematical Modeling
• Scientific Computing
• Machine Learning in Medicine
• +۵ مورد دیگر

Travis B. Thompson, Ph.D. is an Assistant Professor in the Department of Mathematics and Statistics at Texas Tech University, leading the TM4 (Texas Tech Translational and Theoretical Mathematical Modeling and Machine Learning in Medicine) research group. His academic journey includes postdoctoral work at Rice University, Simula Research Laboratory, and the University of Oxford, focusing on mathematics applied to neurodegenerative diseases. Education: Ph.D. in Mathematics from Texas A&M University (2013) Dr. Thompson develops theoretical mathematical models and applies scientific computing and machine learning to study neurological pathologies, particularly Alzheimer’s disease. His work explores complex biological processes on networks, translational healthcare applications, and nutritional security implications. Current research trends integrate neuroimaging data with finite element simulations to model tau progression , amyloid beta dynamics , and glymphatic clearance in age-related diseases. Scientific awards and honors were not explicitly mentioned in the provided materials. Dr. Thompson’s interdisciplinary approach connects computational neuroscience with biomedical engineering , utilizing techniques like diffusion tensor imaging and level set methods to analyze pathological protein spread and brain tissue mechanics . The TM4 research group focuses on network neurodegeneration , personalized medicine , and machine learning diagnostics . Their work spans from microfluidic cancer detection to computational modeling of brain clearance mechanisms , addressing challenges in both neurodegenerative diseases and biomedical engineering through rigorous mathematical frameworks.

• Pharmacokinetics
• Pharmacometrics
• Population pharmacokinetics
• +۵ مورد دیگر

Markus Hovd is a Senior Lecturer at the Section for Pharmacology and Pharmaceutical Biosciences within the Department of Pharmacy at the University of Oslo's Faculty of Mathematics and Natural Sciences. He also maintains an affiliation with the Neurosurgical Department. His work focuses on pharmacokinetic research with applications in clinical practice and personalized medicine. Philosophiae Doctor (PhD), Department of Pharmacy, University of Oslo, 2024 Master of Pharmacy, Department of Pharmacy, University of Oslo, 2019 Hovd's primary research interest centers on the mechanisms behind pharmacokinetic inter-individual variability and the development of models to aid in personalization of medicine. His research methodology includes population- and physiology-based pharmacokinetic models, in vitro-in vivo extrapolation, and clinical trials. His work spans multiple therapeutic areas including kidney transplantation, obesity-related pharmacokinetics, and cerebrospinal fluid dynamics. Analysis of Hovd's publications reveals a strong focus on pharmacokinetic applications in specialized patient populations, particularly kidney transplant recipients and patients who have undergone bariatric surgery. His research demonstrates expertise in population pharmacokinetic modeling, drug transport mechanisms, and the impact of physiological changes on drug disposition. A significant portion of his work addresses the challenges of drug dosing in complex clinical scenarios where standard pharmacokinetic assumptions may not apply. Hovd serves as a representative for temporary teaching staff on both the Teaching Committee and the Department Board at the Department of Pharmacy. His teaching portfolio includes courses in Pharmaceutical Biochemistry, Pharmacotherapy, Pharmaceutical Microbiology, Research Preparation in Biology, and Applied Pharmacokinetics and Dosing in Clinical Practice. Hovd is actively involved in multiple research groups including Pharmacokinetics, Kidney Transplant Medicine, and the KG Jebsen Center for Cerebrospinal Fluid Research, where he contributes his pharmacokinetic expertise to interdisciplinary neuroscience research.

Craig Ferrisمشاهده پروفایل

استاد

• Behavioral Neuroscience
• Neuroimaging
• Neurodegenerative Diseases
• +۱ مورد دیگر

Dr. Craig Ferris is Professor of Psychology at Northeastern University's College of Science with joint appointment in Pharmaceutical Sciences. He directs the Center for Translational NeuroImaging (CTNI) investigating neuropsychiatric disorders through advanced MRI techniques. Research focuses on neuroplasticity, neurodegenerative mechanisms, and psychopharmacology using awake animal MRI. Current investigations examine glymphatic system function, cannabinoid neuropharmacology, and neuropathology of traumatic brain injury across developmental stages. Recent publications explore psychedelic neurobiology, lipidome-brain function relationships, and neurovascular changes in disease models. Studies employ multimodal imaging to track neurobiological changes in real-time during pharmacological challenges. Leadership roles include mentoring doctoral candidates and developing novel neuroimaging methodologies for drug discovery applications.

D.S. Fahmeed Hyderمشاهده پروفایل

استاد

• Magnetic Resonance Imaging
• Neuroimaging
• Molecular Imaging
• +۳ مورد دیگر

D.S. Fahmeed Hyder is a Professor of Biomedical Engineering at Yale University, with additional appointments in Radiology & Biomedical Imaging. He holds a Ph.D. from Yale University and leads the Hyder Lab, which focuses on advancing quantitative and translational imaging technologies using magnetic resonance methods to study brain function and dysfunction at the laminar level. His research integrates multidisciplinary approaches, including molecular imaging, neurophysiology, and material science. Research Interests: Neurovascular and neurometabolic coupling mechanisms Molecular imaging probes for disease diagnostics Functional MRI (fMRI) and metabolic imaging in health and disease Imaging applications for Alzheimer’s, stroke, and cancer Publications: Dr. Hyder’s recent work emphasizes cutting-edge imaging techniques, such as pH-sensitive biosensors, high-resolution fMRI, and multimodal optical imaging. His research highlights include studies on neurovascular dysfunction in Alzheimer’s models, therapeutic interventions for brain injury, and molecular imaging of tumor microenvironments. Awards: Niels Lassen Award (2003), for cerebral blood flow research Early Career Faculty Award (1998), NSF & NIH Pilot Awards from JDRF & Yale-UCL Collaborative (2008, 2013) Labs/Teams: The Hyder Lab collaborates with institutions like UCL and the James S. McDonnell Foundation, advancing translational imaging solutions for clinical applications.

• Neurocritical Care
• Vascular Neurology
• Traumatic Brain Injury
• +۶ مورد دیگر

Dr. Gunjan Y. Parikh serves as an Associate Professor in the Department of Neurology at the University of Maryland School of Medicine, where she also functions as the Medical Director of the UMMC Neuro Critical Care Unit. Her clinical practice focuses on the intersection of neurology and critical care medicine, with particular expertise in managing patients with acute neurological emergencies including traumatic brain injury, intracerebral hemorrhage, and subarachnoid hemorrhage. Dr. Parikh completed her undergraduate education with a BA in Biochemistry from The University of Texas at Austin, followed by her MD from Texas A&M College of Medicine. Her clinical training includes an Internal Medicine internship at St. Vincent's Hospital - Manhattan, Neurology residency at Barrow Neurological Institute at Saint Joseph's Hospital and Medical Center (where she also served as Chief Resident), and specialized fellowship training in Neurocritical Care/Vascular Neurology at Columbia University Medical Center/Weill Cornell Medical Center. She further enhanced her research skills through an NINDS Research Fellowship in Neuroimaging at the National Institutes of Health. Her research program centers on identifying biomarkers during the resuscitation phase of patients with acute brain injuries that determine lesion repair, restoration of function, and recovery of consciousness. This work has led to significant contributions in characterizing the MRI signature of primary microvascular injury after head trauma and other acute brain injuries through both in vivo and ex vivo investigations. Her lab integrates multimodality monitoring with advanced neuroimaging techniques to translate findings to clinical care and develop outcome measures for clinical trials targeting currently untreatable aspects of brain injury such as demyelination and neurodegeneration. Analysis of Dr. Parikh's recent publications reveals a strong focus on translational neuroscience with emphasis on neuroimaging techniques, biomarker discovery, and clinical applications for acute brain injury management. Her work spans from basic science investigations of microvascular injury to clinical studies on patient outcomes, with particular attention to traumatic brain injury, intracerebral hemorrhage, and subarachnoid hemorrhage. Recent publications demonstrate increasing integration of data science approaches for predicting neurological deterioration and developing automated clinical assessment tools. Fellow of the Neurocritical Care Society (2024) Member, American Academy of Neurology Member, Neurocritical Care Society Member, National Neurotrauma Society Dr. Parikh serves as Site Co-PI for the DISCOVERY study (Determinants of Incident Stroke Cognitive Outcomes and Vascular Effects on Recovery) under NINDS/NIA U19 NS115388, and as SubK site-PI for the REACH-ICH study (Race/Ethnicity, Hypertension and Prevention of VCID and Stroke after Intracerebral Hemorrhage) under NINDS/NIH 5R01NS093870-08. Her research has been featured in multiple media outlets including MD Edge Psychiatry, News Medical, and SciTech Daily, highlighting her contributions to understanding vascular injury in traumatic brain injury. As Medical Director of the UMMC Neuro Critical Care Unit, Dr. Parikh leads a multidisciplinary team focused on providing high-reliability, quality care with emphasis on patient experience. Her research group actively investigates cerebral hemodynamics, neuroimaging biomarkers, and clinical decision support tools for patients with acute neurological conditions, with particular attention to improving triage and interhospital transfer of neuroscience patients.

• MRI Technology
• Biomedical Imaging
• Physical Chemistry
• +۳ مورد دیگر

Dr. William M Holmes is a Senior Research Fellow and Senior MRI Physicist at the University of Glasgow's School of Psychology & Neuroscience, affiliated with the Glasgow Experimental MRI Centre. He holds a PhD in Physical Chemistry from the University of Nottingham and specializes in advancing MRI techniques for biomedical and physical sciences. His work bridges physics, neuroscience, and clinical applications, with a focus on cerebral blood flow imaging, glymphatic system dynamics, and disease modeling in rodents. Key roles: MRI method development, neuroimaging biomarkers, porous media analysis Leadership: Glasgow Experimental MRI Centre Research interests emphasize novel MRI applications in stroke, neurological disorders, and material science. Over 80 peer-reviewed publications demonstrate contributions to perfusion imaging, biofilm dynamics, and translational MRI techniques. Recent projects include: Quantitative arterial spin labeling methods Glymphatic system's role in multiple sclerosis Non-invasive rodent disease modeling

Peter J. Basserمشاهده پروفایل

استاد پژوهشی

• Quantitative Imaging
• Tissue Sciences
• Diffusion MRI
• +۷ مورد دیگر

Peter J. Basser is a leading research scientist at the National Institutes of Health (NIH), specifically within the Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD), where he heads the Section on Quantitative Imaging and Tissue Sciences (SQITS). His work bridges physics, engineering, and neuroscience to develop non-invasive MRI methods for probing tissue microstructure, particularly in the brain. His educational background is not explicitly mentioned, but his scientific achievements reflect deep training in biophysics and medical imaging. He earned his Ph.D. and has built a career at NIH as a principal inventor of key neuroimaging technologies. Basser's research focuses on quantitative imaging and tissue sciences , especially using diffusion MRI to study brain structure and function. He pioneered Diffusion Tensor MRI (DTI) , Streamline Tractography , and advanced methods like MAP MRI , CHARMED , and AxCaliber , enabling in vivo measurement of axon diameters and microstructural features previously accessible only through histology. His work aims to translate these tools into clinical use for diagnosing developmental disorders, trauma, and neurodegeneration. The 15 most recent articles reflect a consistent focus on developing novel MRI biomarkers, particularly through diffusion and relaxometry methods. They explore water exchange, restriction, glymphatic clearance, latency connectomes, and cortical microstructure, demonstrating a trajectory toward in vivo MRI histology and precision imaging for pediatric and neurological applications. Scientific Awards: National Academy of Engineering (NAE), Inducted 2020 National Academy of Inventors (NAI) Fellow, 2024 Eduard Rhein Technology Award, 2021 ISMRM Gold Medal, 2008 ISMRM Lauterbur Lecturer, 2020 American Society of Neuroradiology Honorary Member, 2019 Victor M. Haughton Award, 2017 ISMRM Fellow, 2010 AIMBE Fellow Best Paper Award, Frontiers in Physics, 2023 Basser leads a dynamic research group that mentors postdoctoral fellows and trainees, many of whom have received prestigious awards. His lab has secured significant grants from the NIH BRAIN Initiative, NICHD, USUHS, and the Bill & Melinda Gates Foundation. The SQITS lab develops open-source software tools like TORTOISE , dmritool , and HI-SPEED , which are widely used in the neuroimaging community. The lab collaborates with institutions such as Uniformed Services University and participates in major initiatives like the Human Placenta Project and the Human Connectome Project. Basser’s vision is to transform clinical MRI scanners into quantitative scientific instruments for precision medicine and large-scale brain mapping. Labs and Teams: Section on Quantitative Imaging and Tissue Sciences (SQITS), NICHD, NIH Neuropathology-Neuroradiology Integration Core (with USUHS) Advanced Translational Neuroimaging Research & Development Core Diffusion – Data Processing Center (DPC)

Ting Duمشاهده پروفایل

استادیار

• Neuroscience
• Neurology
• Brain Fluid Homeostasis
• +۷ مورد دیگر

Ting Du, M.D., Ph.D., is an Assistant Professor in the Department of Neurology at the University of Rochester Medical Center's School of Medicine and Dentistry. She leads the Du Lab, focusing on brain fluid homeostasis and its role in neurological diseases. Faculty: Assistant Professor, Department of Neurology Institution: University of Rochester Medical Center Lab: Du Lab Collaborations: Nedergaard Lab, Center for Translational Neuromedicine Research Interests: The Du Lab investigates cerebrospinal fluid (CSF) dynamics, glymphatic system function, and cervical lymphatic vessels in Alzheimer's disease, hydrocephalus, and traumatic brain injury. Key projects include: Restoring cervical lymphatic function to improve CSF drainage in aging Characterizing the subarachnoid lymphatic-like membrane (SLYM) in trauma Probing choroid plexus regulation in hydrocephalus Publication Trends: Recent work spans Neuroscience , Neurodegeneration , and Biophysics , with emphasis on: Glymphatic dysfunction in Alzheimer's Arterial pulsation-driven CSF flow Aquaporin-4's role in interstitial fluid Machine learning-based flow quantification Lab Affiliations: The Du Lab is part of the Neuroscience Ph.D. Program and Pathology - Cell Biology of Disease program, collaborating with experts in neuroimaging , fluid dynamics , and neurotherapeutics .

Raag Airanمشاهده پروفایل

استادیار

• Neuroimaging
• Neurointervention
• Ultrasound Techniques
• +۳ مورد دیگر

Raag Airan is an Assistant Professor of Radiology (Neuroimaging and Neurointervention) and by courtesy, Materials Science and Engineering at Stanford University. His work bridges Noninvasive nervous system manipulation Ultrasound and nanoparticle engineering Theranostic applications Behavioral neuroscience His research focuses on Ultrasound-mediated drug delivery systems Neuroimaging of functional connectivity Neuromodulation for chronic pain and psychiatric disorders Glymphatic system modulation Recent publications highlight advancements in Acoustically activatable liposomes Sex-based pharmacological responses Algorithmic psychiatry frameworks Stem cell therapy imaging Deep learning-enhanced ultrasound